ES2073871T3 - Tiazolidin-2,4-dionas en el tratamiento de la hipertension. - Google Patents

Tiazolidin-2,4-dionas en el tratamiento de la hipertension.

Info

Publication number
ES2073871T3
ES2073871T3 ES92308333T ES92308333T ES2073871T3 ES 2073871 T3 ES2073871 T3 ES 2073871T3 ES 92308333 T ES92308333 T ES 92308333T ES 92308333 T ES92308333 T ES 92308333T ES 2073871 T3 ES2073871 T3 ES 2073871T3
Authority
ES
Spain
Prior art keywords
hypertension
tiazolidin
dionas
treatment
choh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92308333T
Other languages
English (en)
Spanish (es)
Inventor
Eric Robert Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2073871T3 publication Critical patent/ES2073871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Removal Of Specific Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES92308333T 1991-09-25 1992-09-14 Tiazolidin-2,4-dionas en el tratamiento de la hipertension. Expired - Lifetime ES2073871T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/765,643 US5175179A (en) 1991-09-25 1991-09-25 Method for treating hypertension

Publications (1)

Publication Number Publication Date
ES2073871T3 true ES2073871T3 (es) 1995-08-16

Family

ID=25074097

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92308333T Expired - Lifetime ES2073871T3 (es) 1991-09-25 1992-09-14 Tiazolidin-2,4-dionas en el tratamiento de la hipertension.

Country Status (17)

Country Link
US (1) US5175179A (ref)
EP (1) EP0534655B1 (ref)
JP (1) JPH05194220A (ref)
KR (1) KR950013756B1 (ref)
AT (1) ATE124259T1 (ref)
AU (1) AU644545B2 (ref)
CA (1) CA2078901A1 (ref)
DE (1) DE69203194T2 (ref)
DK (1) DK0534655T3 (ref)
ES (1) ES2073871T3 (ref)
HU (1) HUT65276A (ref)
IL (1) IL103202A0 (ref)
MX (1) MX9205408A (ref)
MY (1) MY129918A (ref)
NZ (1) NZ244474A (ref)
TW (1) TW209167B (ref)
ZA (1) ZA927307B (ref)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
EP1786814B1 (en) * 2004-08-25 2010-03-31 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
EP1893578A2 (en) * 2005-05-27 2008-03-05 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
AU2007224368A1 (en) * 2006-03-08 2007-09-13 Actelion Pharmaceuticals Ltd New amines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
DE69100282T3 (de) * 1990-02-09 2001-01-11 Pharmacia & Upjohn Co., Kalamazoo Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.

Also Published As

Publication number Publication date
EP0534655A1 (en) 1993-03-31
MY129918A (en) 2007-05-31
DE69203194T2 (de) 1995-11-02
MX9205408A (es) 1993-03-01
AU2532692A (en) 1993-04-22
DE69203194D1 (de) 1995-08-03
KR950013756B1 (ko) 1995-11-15
EP0534655B1 (en) 1995-06-28
US5175179A (en) 1992-12-29
JPH05194220A (ja) 1993-08-03
KR930005621A (ko) 1993-04-20
HU9203052D0 (en) 1992-12-28
AU644545B2 (en) 1993-12-09
CA2078901A1 (en) 1993-03-26
DK0534655T3 (da) 1995-08-28
TW209167B (ref) 1993-07-11
ATE124259T1 (de) 1995-07-15
IL103202A0 (en) 1993-02-21
NZ244474A (en) 1994-01-26
ZA927307B (en) 1994-03-24
HUT65276A (en) 1994-05-02

Similar Documents

Publication Publication Date Title
ES2070628T3 (es) Uso de compuestos analogos a 1,3-oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
FI935675A0 (fi) Pyrazolopyrimidiner
ES2086270T3 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
ES2193142T3 (es) Uso de benzotiofenos para el tratamiento de hipercolesterolemia.
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
RU94045278A (ru) Применение 2-фенил-3-ароилбензтиофенов для ингибирования вазомоторных симптомов и сопутствующих психологических нарушений, ассоциированных с постклимактерическим синдромом
RU94044454A (ru) Ингибитор аутоимунных заболеваний
ES2092646T3 (es) Metanoantracenos como antagonistas de dopamina.
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
ATE137969T1 (de) Benzimidazolverbindungen als antibiotika gegen campylobacter pylon
CA2256514A1 (en) Veterinary use of a pleuromutilin derivative
ES2073871T3 (es) Tiazolidin-2,4-dionas en el tratamiento de la hipertension.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
ES2162813T3 (es) Uso de 3,5-diamino-6-(2,3-diclorofenil)-1,2,4-triazina en la preparacion de un farmaco para el tratamiento de ciertos tipos de dolor y edema.
FI923662A0 (fi) Terapeutiska medel.
ES2061749T3 (es) Compuestos heterociclicos y agentes antiulcerosos.
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.
PT100284A (pt) Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos
IT1224250B (it) Associzione del depiprazolo con la morfina
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 534655

Country of ref document: ES